• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Exicure, Inc.

    Exicure, Inc. Receives Extension from Nasdaq Hearings Panel
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Announces Proposed Settlement of Securities Class Action Litigation
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Announces 1-for-5 Reverse Stock Split
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Announces Additional Adjournment of Special Meeting and Information for Reconvened Special Meeting
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Reports Second Quarter 2024 Financial Results
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Recruits Head of Corporate Development and Bioinformatics
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Receives Positive Listing Determination from Nasdaq
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Reports First Quarter 2024 Financial Results
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Reports Full Year 2023 Financial Results
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Received Nasdaq Notice of a Delisting Determination
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Reports Third Quarter 2023 Financial Results
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-K
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic Alternatives
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Announces Investment in Korean SNS Platform Cyworld
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Reports Full Year 2022 Financial Results and Provides Corporate Update
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Announces Closing of Private Placement Transaction with CBI USA, Inc. and Changes to the Board of Directors
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Announces Termination of AbbVie and Ipsen Collaboration Agreements
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Enters Into Definitive Agreement With CBI USA, Inc. for $5.4 Million Equity Financing and Announces Implementation of Strategic Measure to Reduce Cash Burn and Prioritize Strategic Alternatives
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure Announces Presentation at Chardan’s 6th Annual Genetic Medicines Conference
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Reports Second Quarter 2022 Financial Results and Corporate Progress
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Exicure, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement
    From Exicure, Inc.
    Via Business Wire
    Tickers XCUR
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.